How the Immune Response Affects Tumor Growth in Stem Cell Transplants
Author Information
Author(s): Ralf Dressel, Jan Schindehütte, Tanja Kuhlmann, Leslie Elsner, Peter Novota, Paul Christian Baier, Arne Schillert, Heike Bickeböller, Thomas Herrmann, Claudia Trenkwalder, Walter Paulus, Ahmed Mansouri
Primary Institution: University of Göttingen, Göttingen, Germany
Hypothesis
The immune response plays a critical role in controlling the tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells.
Conclusion
The study found that the immune response significantly influences the tumorigenicity of embryonic stem cells and differentiated neuronal cells, with teratomas forming in immunocompetent hosts but not in allogeneic or xenogeneic hosts.
Supporting Evidence
- Teratomas formed in 95% of syngeneic mice injected with 1×10^6 ES or differentiated cells.
- Undifferentiated ES cells were highly susceptible to killing by rat natural killer cells.
- Immunocompetent allogeneic mice did not develop tumors after injection of ES or differentiated cells.
Takeaway
When scientists put stem cells into mice, the immune system can stop them from growing into tumors, but sometimes they still form tumors if the immune system is weak.
Methodology
The researchers injected mouse embryonic stem cells and differentiated neuronal cells into various types of mice and rats, observing tumor formation and analyzing the immune response.
Potential Biases
Potential bias in the selection of animal models and the interpretation of immune responses.
Limitations
The study primarily focused on mouse models, which may not fully represent human responses.
Participant Demographics
Mice and rats of various strains, including syngeneic, allogeneic, and xenogeneic hosts.
Statistical Information
P-Value
p=0.0673
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website